SCIENTIFIC BACKGROUND

ADRA2B, CACNB4, CASR, CERS1, CLCN2, CNTN2, CSTB, EFHC1, EPM2A, GABRA1, GABRD, GOSR2, KCNC1, KCNMA1, KCTD7, LMNB2, NHLRC1, PRDM8, PRICKLE1, PRICKLE2, SCARB2, SLC6A1, TBC1D24

  • Epilepsy with myoclonic-atonic seizures (MAE) (SLC6A1, AD)
  • Familial infantile myoclonic epilepsy (FIME) (TBC1D24, AR)
  • Familial myoclonic epilepsy of adulthood 2 (ADRA2B, AD)
  • Familial myoclonic epilepsy of adulthood 5 (CNTN2, AR)
  • Generalized epilepsy with paroxysmal dyskinesia (GEPD) (KCNMA1, AD)
  • Idiopathic generalized epilepsy type 8 (CASR, AD)
  • Juvenile myoclonic epilepsy type 1 (EJM1) (EFHC1, AD)
  • Juvenile myoclonic epilepsy type 5 (EJM5) (GABRA1, AD)
  • Juvenile myoclonic epilepsy type 6 (EJM6) (CACNB4, AD)
  • Juvenile myoclonic epilepsy type 7 (EJM7) (GABRD, AD)
  • Juvenile myoclonic epilepsy type 8 (EJM8) (CLCN2, AD)
  • Progressive myoclonic epilepsy type 10 (PME10) (PRDM8, AR)
  • Progressive myoclonic epilepsy type 1A (PME1A) (Unverricht and Lundborg) (CSTB, AR)
  • Progressive myoclonic epilepsy type 1B (PME1B) (Unverricht and Lundborg) (PRICKLE1, AR)
  • Progressive myoclonic epilepsy type 2A (PME2A; Lafora) (EPM2A, AR)
  • Progressive myoclonic epilepsy type 2B (PME2B; Lafora) (NHLRC1, AR)
  • Progressive myoclonic epilepsy type 3 with or without intracellular inclusions (PME3) (KCTD7, AR)
  • Progressive myoclonic epilepsy type 4 with or without renal failure (PME4) (SCARB2, AR)
  • Progressive myoclonic epilepsy type 5 (PME5) (PRICKLE2, AD)
  • Progressive myoclonic epilepsy type 6 (PME6) (GOSR2, AR)
  • Progressive myoclonic epilepsy type 7 (PME7) (KCNC1, AD)
  • Progressive myoclonic epilepsy type 8 (PME8) (CERS1, AR)
  • Progressive myoclonic epilepsy type 9 (PME9) (LMNB2, AR)

 

Disorders are inherited in an autosomal dominant (AD) or autosomal recessive (AR) pattern. Genes in bold are core genes.

 

Epilepsy, juvenile myoclonic

Genes: CACNB4, CASR, CLCN2, EFHC1, GABRA1, GABRD, KCNMA1, SLC6A1, TBC1D24

 

Epilepsy, progressive myoclonic

Genes: CERS1, CSTB, EPM2A, GOSR2, KCNC1, KCTD7, LMNB2, NHLRC1, PRDM8, PRICKLE1, SCARB2

 

For detailed information on epilepsies and diagnostics, please visit our overview page EPILEPSY.

GENES

ADRA2B, CACNB4, CASR, CERS1, CLCN2, CNTN2, CSTB, EFHC1, EPM2A, GABRA1, GABRD, GOSR2, KCNC1, KCNMA1, KCTD7, LMNB2, NHLRC1, PRDM8, PRICKLE1, PRICKLE2, SCARB2, SLC6A1, TBC1D24

ASSOCIATED TESTS

How to order

LATEST ARTICLES

Every year on April 25th, DNA Day celebrates the discovery of DNA’s double helix and the advances we’ve made in understanding genetics. D...

Read more

Neurodevelopmental disorders (NDDs) have diverse genetic origins, making diagnosis challenging. A new study analyzing over 1,100 pediatric patients f...

Read more

Colorectal cancer (CRC) remains one of the most prevalent and deadly cancers worldwide, with a significant number of cases presenting at an advanced ...

Read more

Carrier screening is a genetic test designed to identify whether an individual carries a gene with changes (mutations) associated with inherited diso...

Read more

Trisomy 13, also known as Patau syndrome, is a genetic condition in which cells in the body have three copies of chromosome 13 instead of two. The co...

Read more

The human brain develops through a complex series of events, with genes carefully regulating the formation of neurons and glial cells. A recent study...

Read more

Rare diseases affect between 300 and 400 million people worldwide – more than cancer and AIDS combined [1, 2], but despite this, many people face a...

Read more

Rosalind Elsie Franklin was a brilliant and meticulous research scientist whose interdisciplinary work made fundamental contributions to various area...

Read more

February, designated as Cancer Awareness Month, marks a time to reflect on the remarkable progress made in cancer research and to inspire hope for th...

Read more

Introduction Cardiovascular disease (CVD) is a major health issue as it remains a leading cause of death worldwide [1]. CVD is responsible for mor...

Read more